A Multicenter, Open-Label, Randomized Controlled Trial of a Dual Early Intervention Approach Combining Standard Care and Corticosteroids for Elderly Patients with Mild to Moderate COVID-19 (BEAT-COV Study) - Summary - MDSpire

A Multicenter, Open-Label, Randomized Controlled Trial of a Dual Early Intervention Approach Combining Standard Care and Corticosteroids for Elderly Patients with Mild to Moderate COVID-19 (BEAT-COV Study)

  • By

  • Qiaoling Ruan

  • Yanliang Zhang

  • Tingting Zhao

  • Feng Zhu

  • Xi Liu

  • Ran Cao

  • Yongzhong Li

  • Xiaoqiang Zhang

  • Wei Song

  • Jiawei Geng

  • Deming Zou

  • Yuanyuan Li

  • Liaoyun Zhang

  • Chao Wu

  • Yuanbo Lan

  • Xiangchun Ding

  • Fuli Huang

  • Jiqin Wu

  • Feng Sun

  • Lingyun Shao

  • Wenhong Zhang

  • March 6, 2026

  • 0 min

Share

Objective:

To evaluate the efficacy of corticosteroids in combination with standard care for elderly patients with mild to moderate COVID-19, focusing on disease progression and mortality rates.

Key Findings:
  • Corticosteroids may reduce disease progression risk in elderly patients with mild to moderate COVID-19, although the study's premature termination limits definitive conclusions.
  • The study was terminated prematurely due to low prevalence of COVID-19 and declining severe cases, impacting the robustness of the findings.
Interpretation:

The findings suggest that corticosteroids could be a beneficial addition to standard care for elderly patients with mild to moderate COVID-19, although further research is needed.

Limitations:
  • The trial was terminated early, limiting the sample size and potential findings, which may affect the generalizability of the results.
  • Inconsistencies in prior studies regarding corticosteroid effectiveness in mild to moderate COVID-19 may complicate interpretation.
Conclusion:

Targeted interventions for elderly patients with COVID-19 remain crucial, and corticosteroids may play a role in managing this vulnerable population, warranting further research.

Original Source(s)

A Multicenter, Open-Label, Randomized Controlled Trial of a Dual Early Intervention Approach Combining Standard Care and Corticosteroids for Elderly Patients with Mild to Moderate COVID-19 (BEAT-COV Study)

  • by Qiaoling Ruan, Yanliang Zhang, Tingting Zhao, Feng Zhu, Xi Liu, Ran Cao, Yongzhong Li, Xiaoqiang Zhang, Wei Song, Jiawei Geng, Deming Zou, Yuanyuan Li, Liaoyun Zhang, Chao Wu, Yuanbo Lan, Xiangchun Ding, Fuli Huang, Jiqin Wu, Feng Sun, Lingyun Shao, Wenhong Zhang

  • March 6, 2026

Related Content

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

Correction: Neurological manifestations of SARS-CoV-2 infection: protocol for a sub-analysis of the COVID-19 critical care consortium observational study

Clinical Characteristics and Outcomes of Invasive Pulmonary Aspergillosis in Patients with Influenza Compared to COVID-19: A Retrospective Cohort Analysis